High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 347758)

Published in Infect Immun on November 01, 1982

Authors

H Okamura, K Kawaguchi, K Shoji, Y Kawade

Articles cited by this

Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. J Immunol (1973) 3.88

PATTERNS OF INTERFERON APPEARANCE IN MICE INFECTED WITH BACTERIA OR BACTERIAL ENDOTOXIN. Nature (1964) 3.32

Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infect Immun (1973) 2.73

Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15

Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. Infect Immun (1979) 1.89

Classification of interferons with antibody to immune interferon. Cell Immunol (1980) 1.49

An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer. J Interferon Res (1980) 1.28

Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells. Infect Immun (1979) 1.25

Tumor regression caused by endotoxins and mycobacterial fractions. J Natl Cancer Inst (1975) 1.17

Antigenicity of mouse interferons: distinct antigenicity of the two L cell interferon species. Virology (1980) 1.15

Galactose oxidase-induced blastogenesis of human lymphocytes and the effect of macrophages on the reaction. Clin Exp Immunol (1975) 1.09

Production of antibodies against mouse immune T (type II) interferon and their neutralizing properties. J Gen Virol (1980) 1.01

Affinity chromatographic analysis of murine interferons induced by viruses and by T and B cell stimulants. Ann Immunol (Paris) (1977) 0.94

Induction of interferon production in mouse spleen cell cultures by corynebacterium parvum. Cell Immunol (1978) 0.93

The induction of at least two distinct types of interferon in mouse spleen cell cultures by Corynebacterium parvum. Cell Immunol (1981) 0.88

Antigenic cross-reaction between the alpha types of human and mouse interferon. Antiviral Res (1981) 0.87

Effect of Corynebacterium parvum on human T-lymphocyte interferon production and T-lymphocyte proliferation in vitro. Cancer Res (1978) 0.86

Mechanisms in the in vivo release of lymphokines. II. Regulation of in vivo release of type II interferon IFN gamma. Cell Immunol (1981) 0.84

[Purfication of staphylococcal enterotoxins A and C and preparation of anti-enterotoxin sera]. Nihon Saikingaku Zasshi (1975) 0.82

Properties of interferon induced by purified protein derivative of tuberculin in mice sensitized with BCG or cell-wall skeleton of BCG. Gan (1979) 0.80

Articles by these authors

(truncated to the top 100)

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature (1990) 8.94

Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science (1997) 5.16

Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol (2001) 5.02

Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity (1998) 4.70

Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature (1997) 4.44

Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell (1997) 3.79

IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol (1998) 3.56

Molecular mechanisms of the biological clock in cultured fibroblasts. Science (2001) 3.46

Cerebral ventriculitis associated with Achromobacter xylosoxidans. J Clin Pathol (1978) 2.86

Thyroplasty as a new phonosurgical technique. Acta Otolaryngol (1975) 2.84

Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol (1996) 2.80

Structure and expression of a cloned cDNA for mouse interferon-beta. J Biol Chem (1983) 2.61

Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev (2001) 2.52

Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol Cell (1998) 2.44

IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci U S A (1999) 2.35

Preparation and some properties of yeast mitochondria. J Biol Chem (1966) 2.32

Characterization of rapidly labeled ribonucleic acid of animal cells in culture. Biochim Biophys Acta (1965) 2.15

Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun (1999) 2.14

Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun (1989) 2.13

Catabolite repression and derepression of arylsulfatase synthesis in Klebsiella aerogenes. J Bacteriol (1974) 2.01

Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell (1988) 2.00

Dimerization and nuclear entry of mPER proteins in mammalian cells. Genes Dev (2000) 1.98

IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut (2000) 1.95

A light-independent oscillatory gene mPer3 in mouse SCN and OVLT. EMBO J (1998) 1.92

Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci U S A (1997) 1.92

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med (1997) 1.89

IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol (2000) 1.86

IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol (1996) 1.85

Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism. Genes Dev (2001) 1.82

Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol (2001) 1.82

A new mammalian period gene predominantly expressed in the suprachiasmatic nucleus. Genes Cells (1998) 1.76

The 5' upstream region of mPer1 gene contains two promoters and is responsible for circadian oscillation. Curr Biol (2000) 1.74

IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol (1998) 1.73

Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun (1997) 1.71

Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity (1999) 1.67

Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am J Respir Crit Care Med (2000) 1.65

Forskolin induces circadian gene expression of rPer1, rPer2 and dbp in mammalian rat-1 fibroblasts. FEBS Lett (2000) 1.64

Regulation of tyramine oxidase synthesis in Klebsiella aerogenes. J Bacteriol (1976) 1.62

Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J Immunol (2001) 1.62

IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol (1997) 1.62

Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol (2001) 1.60

Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol Biol Cell (1997) 1.59

A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J Immunol (1997) 1.58

Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol (1997) 1.58

Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J Neurochem (1997) 1.57

Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol (1999) 1.57

Analysis of a suppressor mutation ssb (kinC) of sur0B20 (spo0A) mutation in Bacillus subtilis reveals that kinC encodes a histidine protein kinase. J Bacteriol (1995) 1.56

Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens. J Exp Med (1986) 1.55

Genetic control of arylsulfatase synthesis in Klebsiella aerogenes. J Bacteriol (1977) 1.55

IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol (1997) 1.55

Tyramine oxidase and regulation of arylsulfatase synthesis in Klebsiella aerogenes. J Bacteriol (1977) 1.51

Recent modifications in thyroplasty type I. Ann Otol Rhinol Laryngol (1989) 1.50

Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol (1996) 1.49

Cystic papillary carcinoma of the thyroid gland: a new sonographic sign. Clin Radiol (1991) 1.49

IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol (1999) 1.48

Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation (1998) 1.47

IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol (2000) 1.46

Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest (1998) 1.44

Role of DBP in the circadian oscillatory mechanism. Mol Cell Biol (2000) 1.44

Per1 and Per2 gene expression in the rat suprachiasmatic nucleus: circadian profile and the compartment-specific response to light. Neuroscience (1999) 1.44

Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev (2000) 1.42

Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage (2000) 1.40

Graft replacement of pararenal inferior vena cava for leiomyosarcoma with the use of venous bypass. Surgery (1993) 1.40

Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations. Infect Immun (1992) 1.40

Postnatal development and sex difference in neurons containing estrogen receptor-alpha immunoreactivity in the preoptic brain, the diencephalon, and the amygdala in the rat. J Comp Neurol (1997) 1.39

A psychosocial group intervention for Japanese women with primary breast carcinoma. Cancer (2000) 1.39

Structure of a quinohemoprotein amine dehydrogenase with an uncommon redox cofactor and highly unusual crosslinking. Proc Natl Acad Sci U S A (2001) 1.38

View of a mouse clock gene ticking. Nature (2001) 1.36

Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer (2000) 1.35

Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. J Biol Chem (1982) 1.32

Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res (1994) 1.32

Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J Immunol (1998) 1.31

Gonadotrophin-releasing hormone pulse generator activity in the hypothalamus of the goat. J Neuroendocrinol (2009) 1.31

Identification of DBC1 as a transcriptional repressor for BRCA1. Br J Cancer (2010) 1.31

Thyroplasty type I (lateral compression) for dysphonia due to vocal cord paralysis or atrophy. Acta Otolaryngol (1976) 1.31

Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol (1997) 1.30

An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer. J Interferon Res (1980) 1.28

IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J Immunol (1998) 1.28

De novo synthesis of Escherichia coli glycogen is due to primer associated with glycogen synthase and activation by branching enzyme. Arch Biochem Biophys (1978) 1.28

Torsion of the wandering spleen: CT and angiographic appearance. J Comput Assist Tomogr (1995) 1.26

Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. Gynecol Oncol (2001) 1.26

Solution structure of a telomeric DNA complex of human TRF1. Structure (2001) 1.25

IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol (1999) 1.24

Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J Immunol (1999) 1.22

Quantitation of neutralization of interferon by antibody. Methods Enzymol (1986) 1.22

The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol (2000) 1.21

Submucosal tunneling using endoscopic submucosal dissection for peritoneal access and closure in natural orifice transluminal endoscopic surgery: a porcine survival study. Endoscopy (2009) 1.20

Two-site interaction of nuclear factor of activated T cells with activated calcineurin. J Biol Chem (1998) 1.20

Analysis of ribosomes from viomycin-sensitive and -resistant strains of Mycobacterium smegmatis. J Bacteriol (1972) 1.20

Nonphotic entrainment by 5-HT1A/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiasmatic nuclei. J Neurosci (2000) 1.19

A novel in vitro experimental model for ovarian endometriosis: the three-dimensional culture of human ovarian surface epithelial cells in collagen gels. Fertil Steril (1999) 1.19

Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development. Dev Biol (1997) 1.18

IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol (2001) 1.18

Biosynthesis of bacterial glycogen. Purification and properties of the Escherichia coli B ADPglucose:1,4-alpha-D-glucan 4-alpha-glucosyltransferase. Biochemistry (1976) 1.18

Castleman disease presenting with ophthalmic signs and symptoms. Am J Ophthalmol (1999) 1.17

Transcatheter arterial embolization of obstetric and gynaecological bleeding: efficacy and clinical outcome. Br J Radiol (1994) 1.17

IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int Immunol (1999) 1.16

Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation (2001) 1.16

Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate. Infect Immun (1986) 1.16

MR imaging of the fetus by a HASTE sequence. AJR Am J Roentgenol (1997) 1.15